Latest filing published 05 Feb 2019 for Aclaris Therapeutics, Inc..
Insider track record
Brett Fair: trading record in brief
Brett Fair is a declared insider of Aclaris Therapeutics, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 7 May 2018 to 1 February 2019, the count stands at 8 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 5 February 2019, reports an option exercise in Aclaris Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Brett Fair
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,875 sharesCommon StockSEC:0001209191-19-007486:0
- 1,308 shares@ US$6.9626.5% of flowCommon StockSEC:0001209191-19-007486:1
- 498 shares@ US$6.309.2% of flowCommon StockSEC:0001209191-18-063802:1
- 1,750 sharesCommon StockSEC:0001209191-18-063802:0
- 288 shares@ US$7.316.2% of flowCommon StockSEC:0001209191-18-063367:1
- 1,013 sharesCommon StockSEC:0001209191-18-063367:0
- 4,050 sharesCommon StockSEC:0001209191-18-028858:0
- 1,153 shares@ US$18.1058.2% of flowCommon StockSEC:0001209191-18-028858:1
8 of 8 declarations
